CVE-2025-12699The ZOLL ePCR IOS application reflects unsanitized user input into a WebView.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
The ZOLL ePCR IOS application reflects unsanitized user input into a WebView. Attacker-controlled strings placed into PCR fields (run number, incident, call sign, notes) are interpreted as HTML/JS when the app prints or renders that content. In the proof of concept (POC), injected scripts return local file content, which would allow arbitrary local file reads from the app's runtime context. These local files contain device and user data within the ePCR medical application, and if exposed, would allow an attacker to access protected health information (PHI) or device telemetry.
- CVSS
- 5.5 MEDIUM (v3.1, NVD)CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
- Weakness (CWE)
- CWE-538
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-041-01.json
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-041-01
- https://www.zolldata.com/contact-us.
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.